Search | Browse by Day | Author Index

Author Index: K

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Kachan, N.
  • USING THE MEANS-END CHAIN APPROACH TO MAP CONSUMER DECISION MAKING: THE CASE OF NATURAL HEALTH PRODUCTS
    • Kahn, V.
  • IMPRECISE DEFINITIONS OF “PRECISE”: PREFERENCES FOR PRECISION DEPEND ON CONTEXT
    • Kaimal, A.
  • COST EFFECTIVENESS OF ANTENATAL STEROIDS IN LATE PRETERM PREGNANCIES
  • UNDERLYING DIMENSIONS OF SATISFACTION WITH LABOR AND DELIVERY EXPERIENCE: AN EXPLORATORY FACTOR ANALYSIS
    • Kakihara, Y.
  • DEVELOPMENT OF DECISION SUPPORT SYSTEM FOR SUBJECTS TESTED POSITIVE FOR CANCER
    • Kaldjian, L. C.
  • THE MOST COMMONLY MISSED DIAGNOSES IN PRIMARY CARE
    • Kaliyadan, A.
  • A CASE OF IATROGENIC HYPERTHYROIDISM
  • HIV – ESTABLISHMENT AND PERPETUATION OF AN INCORRECT DIAGNOSIS
    • Kaliyadan, M. P.
  • A CASE OF IATROGENIC HYPERTHYROIDISM
  • HIV – ESTABLISHMENT AND PERPETUATION OF AN INCORRECT DIAGNOSIS
    • Kallen, M. A.
  • THE IMPACT OF PATIENT-PHYSICIAN RELATIONSHIP COMPONENTS ON PHYSICIAN TRUST AND TREATMENT ADHERENCE IN PATIENTS WITH RHEUMATIC DISEASE
    • Kaltman, J.
  • A MODELED ECONOMIC EVALUATION OF ALTERNATIVE STRATEGIES TO REDUCE SUDDEN CARDIAC DEATH IN YOUNG ATHLETES
    • Kamat, S.
  • OBSERVED VERSUS RECOMMENDED PATIENT PRESCRIPTION REFILL BEHAVIOUR - ASSESSMENT OF ADALIMUMAB AND ETANERCEPT PRESCRIPTION GAPS FOR THE FIRST YEAR OF TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS
    • Kane, R. L.
  • HOW MUCH NEGATIVE MARGIN IS ENOUGH FOR PATIENTS WITH DUCTAL CARCINOMA IN SITU RECEIVING BREAST CONSERVING SURGERY WITH OR WITHOUT RADIOTHERAPY? A BAYESIAN META-ANALYSIS
    • Kapoor, W. N.
  • THE ASSOCIATIONS OF MENOPAUSE AND HEALTH-RELATED QUALITY OF LIFE WITH HEALTH SERVICES UTILIZATION: RESULTS FROM THE STRIDE STUDY
    • Kassed, C. A.
  • MISSED DIAGNOSES OF ACUTE MYOCARDIAL INFARCTION IN THE EMERGENCY DEPARTMENT: AN EXPLORATION USING HCUP DATA
    • Kattan, M. W.
  • THE MISCALIBRATION CURVE: A NOVEL PLOT TO ASSESS CALIBRATION ERROR OF A PREDICTION MODEL
    • Kattar, M.
  • POSTNATAL UMBILICAL CORD BLOOD TESTING: PROLIFERATION OF CONFOUNDING NON-VALUE ADDED LABORATORY TESTING
    • Katz, D.
  • ATTITUDES OF EMERGENCY NURSES TOWARD THE DELIVERY OF SMOKING CESSATION COUNSELING
    • Katz, J. N.
  • TREATING HIP AND KNEE OSTEOARTHRITIS: DO PATIENTS WHO CHOOSE SURGERY MAKE BETTER DECISIONS?
    • Kaufman, P.
  • SHARED DECISION MAKING FOR WOMEN WITH BREAST CANCER: KNOWLEDGE, VALUES, AND DECISIONAL CONFLICT OVER TIME
    • Kaufmann, E.
  • DETECT AND CORRECT THE LIES THAT DATA IN MEDICAL STUDIES TELL: WHICH TYPE OF META-ANALYSIS?
  • THE PSYCHOMETRIC BEAUTY OF EXPERT MODELS: A PSYCHOMETRIC EVALUATION OF LINEAR VS. NON-LINEAR MEDICAL EXPERT MODELS IN LENS-MODEL TASKS
  • PSYCHOLOGY OF MEDICAL DECISION MAKING II: MODELING JUDGMENT, THE BRUNSWIKIAN APPROACH
    • Kaushal, R.
  • REVIEW OF PRESCRIPTION MODIFICATIONS: A NOVEL STRATEGY TO ASSESS PHYSICIAN RESPONSE TO MEDICATION ALERTS
    • Kearing, S.
  • HIP AND KNEE OSTEOARTHRITIS: CAN DECISION AIDS INFLUNCE PATIENT TREATMENT CHOICE AND SATISFACTION WITH OUTCOMES?
  • TREATING HIP AND KNEE OSTEOARTHRITIS: DO PATIENTS WHO CHOOSE SURGERY MAKE BETTER DECISIONS?
  • SHARED DECISION MAKING FOR WOMEN WITH BREAST CANCER: KNOWLEDGE, VALUES, AND DECISIONAL CONFLICT OVER TIME
  • DO TESTIMONIALS IN A COLON CANCER SCREENING DECISION AID INFLUENCE PATIENT DECISION MAKING?
    • Keech, T.
  • DECISION AIDS NEAR THE END-OF-LIFE, A PILOT RANDOMIZED CONTROLLED TRIAL AND QUALITATIVE EXIT INTERVIEWS
  • CONFRONTING THE DEATH TABOO: DEVELOPMENT OF LANGUAGE AND PROCESSING EXERCISES ACCEPTABLE FOR CONSTRUCTING DEATH TRADE-OFF PREFERENCES
    • Kent, D. M.
  • WILLINGNESS TO PAY FOR PREDICTIVE DIAGNOSTIC INFORMATION WITH NO IMMEDIATE TREATMENT IMPLICATIONS: A SURVEY OF U.S. RESIDENTS
    • Kerber, K.
  • NYSTAGMUS ASSESSMENTS DOCUMENTED BY EMERGENCY PHYSICIANS IN ACUTE DIZZINESS PRESENTATIONS: A TARGET FOR DECISION SUPPORT?
    • Kerr, S.
  • ECONOMIC EVALUATION OF MONITORING VIROLOGIC RESPONSES TO ANTIRETROVIRAL THERAPY IN HIV-INFECTED CHILDREN IN RESOURCE-LIMITED SETTINGS
    • Keskinocak, P.
  • THE IMPACT OF MASS CHANGES IN SOCIAL MIXING PATTERNS ON THE COURSE OF AN INFLUENZA PANDEMIC
    • Khan, K.
  • SHOULD HEPATITIS B SCREENING BE ADDED TO THE UNITED STATES IMMIGRATION MEDICAL EXAM? A COST-UTILITY ANALYSIS
    • Khan, T.
  • NON-INVASIVE CARDIAC IMAGING TECHNOLOGIES FOR THE DIAGNOSIS OF CORONARY ARTERY DISEASE: A MEGA-HTA TO INFORM POLICY DECISION MAKING
    • Khazeni, N.
  • COST EFFECTIVENESS OF STOCKPILING PROTECTIVE FACEWEAR FOR AN INFLUENZA PANDEMIC
    • Khor, S.
  • HOW ATTRACTIVE DOES A SET OF GUIDELINES HAVE TO BE TO WARRANT CORRECT ADOPTION AND UTILIZATION? THE USE AND MISUSE OF AN INFLUENTIAL SET OF GUIDELINES FOR USING COST-EFFECTIVENESS ANALYSIS
    • Khoury, H.
  • BRIDGING MULTICRITERIA DECISION ANALYSIS (MCDA) WITH HEALTH TECHNOLOGY ASSESSMENT (HTA) FOR POLICY AND CLINICAL DECISIONMAKING: CASE STUDIES IN CANADA AND SOUTH AFRICA
    • Kilbridge, K.
  • CHALLENGES TO NUMERACY ASSESSMENT AND RISK COMMUNICATION IN AN UNDERSERVED POPULATION
    • Kim, J. J.
  • MODELING HISTORICAL TRENDS IN CERVICAL CANCER USING A MULTI-COHORT MODEL
    • Kim, R.
  • THE IMPACT OF HEPATITIS C ON WORK PRODUCTIVITY AMONG AFRICAN-AMERICAN AND HIGH VIRAL LOAD PATIENTS
    • Kimmel, A. D.
  • DECISION MAKER PRIORITIES FOR PROVIDING ANTIRETROVIRAL THERAPY IN HIV-INFECTED SOUTH AFRICAN ADULTS: A QUALITATIVE ASSESSMENT
  • PATIENT- AND POPULATION-LEVEL HEALTH CONSEQUENCES OF DISCONTINUING ANTIRETROVIRAL THERAPY (ART) IN RESOURCE-LIMITED SETTINGS
    • Kimmelman, J.
  • CAN IPDAS CRITERIA BE USED TO ASSESS THE QUALITY OF INFORMED CONSENT DOCUMENTS?
    • Kimmie, C.
  • DO MEN SCHEDULING A PROSTATE BIOPSY BENEFIT FROM INFORMATION ABOUT POTENTIAL TREATMENT OPTIONS?
    • King, N.
  • WHO CARES ABOUT HEALTH INEQUALITY? FINDINGS FROM THE WORLD HEALTH SURVEY
    • Klassen, A.
  • PARENTS OF CHILDREN WITH HEALTH PROBLEMS: HOW DOES THEIR HEALTH CHANGE OVER TIME?
    • Klemp, M.
  • HEALTH ECONOMIC EVALUATION OF ANTIPLATELET THERAPY IN THE SECONDARY PREVENTION OF STROKE
  • HEALTH ECONOMIC EVALUATION OF INTRAVENOUS THROMBOLYTIC TREATMENT WITHIN 3 HOURS AND BETWEEN 3 AND 5 HOURS AFTER ONSET OF ACUTE ISCHEMIC STROKE
  • COST-EFFECTIVENESS OF DRUGS FOR SMOKING CESSATION IN NORWAY
  • COST-UTILITY OF ACUTE TREATMENT OF PATIENTS IN STROKE UNITS (WITH OR WITHOUT EARLY SUPPORTED DISCHARGE)
    • Kloss, H. N.
  • IMPACT OF QUANTITATIVE INFORMATION AND A NUDGE ON ATTITUDES TOWARD COLORECTAL CANCER SCREENING
    • Knight, N. B.
  • THE IMPACT ON USERS OF A WEB BASED DIAGNOSIS DECISION SUPPORT SYSTEM
    • Knight, S. J.
  • CONCURRENT ORAL SESSION F: PREFERENCES
    • Knight, T. K.
  • THE IMPACT OF DEPRESSION ON MEDICATION ADHERENCE IN A CALIFORNIA MEDICAID POPULATION WITH CARDIOVASCULAR DISEASE
  • FINITE MIXTURE MODELING ANALYSES OF HEALTHCARE UTILIZATION IN PATIENTS WITH TYPE II DIABETES AND COMORBID CARDIOVASCULAR DISEASE
    • Knops, A. M.
  • DEVELOPMENT AND VALIDATION OF A DECISION BURDEN SCALE
  • DO SURGEONS FOSTER SHARED DECISION MAKING IN THEIR COMMUNICATION WITH PATIENTS ABOUT THEIR ABDOMINAL AORTIC ANEURYSM?
    • Knudsen, A. B.
  • DEVELOPMENT OF A BLOOD TEST TO SCREEN FOR COLORECTAL CANCER: WHICH FEATURES ARE IMPORTANT? A COST-EFFECTIVENESS APPROACH
    • Kodenchery, M. M.
  • SPECIALIZATION INDUCED TUNNEL VISION – A CAUSE OF LIFE THREATENING DIAGNOSTIC DELAY
    • Koenig, B. A.
  • PERSONALIZED PREVENTIVE MEDICINE AND ITS CONSEQUENCES: THE IMPACT OF PREDICTIVE GENOMIC TESTING ON RISK PERCEPTION AND WORRY
    • Koffijberg, H.
  • COST-EFFECTIVENESS ANALYSIS OF DIAGNOSTIC TESTS: AN EXAMPLE STUDY OF TRANSESOPHAGEAL ECHOCARDIOGRAPHY TO DIAGNOSE THE PRESENCE OF ASCENDING AORTIC ATHEROSCLEROSIS IN CARDIAC SURGERY PATIENTS
  • COMMUNICATING UNCERTAINTY IN GENERALIZED COST-EFFECTIVENESS ANALYSES: VISUALIZING OPTIMAL INTERVENTIONS AND STRATEGIES
    • Kohen, D.
  • PARENTS OF CHILDREN WITH HEALTH PROBLEMS: HOW DOES THEIR HEALTH CHANGE OVER TIME?
    • Kohn, M. A.
  • EVIDENCE-BASED DIAGNOSIS (ROC CURVES, INTERVAL LIKELIHOOD RATIOS AND BEYOND)
    • Kolm, P.
  • COMPARISON OF METHODS FOR ANALYZING COST-EFFECTIVENESS FROM REGISTRY DATA
    • Komaba, H.
  • COST-EFFECTIVE TREATMENT THRESHOLDS FOR OSTEOPENIC POSTMENOPAUSAL WOMEN IN JAPAN
    • Kong, N.
  • SECOND-LOOK ENDOSCOPY FOR BLEEDING PEPTIC ULCER DISEASE: A DECISION- AND COST-EFFECTIVENESS ANALYSIS
    • Koning, C. C.
  • COMMUNICATION ABOUT CANCER PATIENTS' APPRAISAL OF TREATMENT ASPECTS AND ALTERNATIVES: AN EXPLORATIVE STUDY
    • Koren, G.
  • DISCRETE CHOICE EXPERIMENT TO ASSESS PUBLIC PREFERENCES FOR COUNSELING AND INFORMATION SERVICES REGARDING ANTI-DEPRESSANT USE DURING PREGNANCY
    • Korfage, I. J.
  • INFORMED CHOICE ON PAP SMEAR STILL LIMITED BY LACK OF KNOWLEDGE ON THE MEANING OF FALSE POSITIVE OR FALSE NEGATIVE TEST RESULTS
  • PREFERENCES FOR HPV VACCINATION: A COMPARISON OF GIRLS AND PARENTS
    • Kornfeld, J.
  • ONCOLOGISTS' ATTITUDES AND BELIEFS ABOUT PATIENT PARTICIPATION IN CANCER CLINICAL TRIALS
    • Kornor, H.
  • HUMAN PAPILLOMAVIRUS TESTING FOR THE DETECTION OF CERVICAL INTRAEPITHELIAL NEOPLASIA: A SYSTEMATIC REVIEW
    • Kostopoulou, O.
  • CONCURRENT ORAL SESSION I: SJDM JOINT SESSION
  • METHODS FOR STUDYING THE COGNITIVE CAUSES OF DIAGNOSTIC ERROR: A SYSTEMATIC REVIEW
  • RESEARCH METHODS PANEL DISCUSSION: IS THERE A RIGHT WAY FORWARD?
    • Kotak, S. V.
  • DEVELOPMENT OF A MULTIATTRIBUTE INSTRUMENT FOR ESTIMATING UTILITIES (PREFERENCE WEIGHTS) IN PEOPLE WITH GLAUCOMA FROM THE NATIONAL EYE INSTITUTE VISION FUNCTION QUESTIONNAIRE
    • Krahn, M. D.
  • THE COST-EFFECTIVENESS ANALYSIS OF FIVE NON-INVASIVE CARDIAC IMAGING TECHNOLOGIES IN ONTARIO
  • AN ECONOMIC ANALYSIS OF HEART AND STROKE FOUNDATION OF ONTARIO'S HYPERTENSION MANAGEMENT INITIATIVE (HMI)
  • COST EFFECTIVENESS OF SCREENING IMMIGRANTS IN CANADA FOR HEPATITIS B
  • PHARMCOGENETIC TESTING AND EVIDENCE-BASED DECISION-MAKING IN ONTARIO: THE APPLICATION OF ONTARIO'S DECISION DETERMINANTS FRAMEWORK TO THE EVALUATION OF PHARMACOGENETIC TESTS
  • USING THE MEANS-END CHAIN APPROACH TO MAP CONSUMER DECISION MAKING: THE CASE OF NATURAL HEALTH PRODUCTS
  • SMDM KEYNOTE PRESENTATION
  • IS A MASS IMMUNIZATION PROGRAM FOR PANDEMIC (H1N1) 2009 GOOD VALUE FOR MONEY? EVIDENCE FROM THE CANADIAN EXPERIENCE
  • THE CURRENT AND FUTURE BURDEN OF HEPATITIS C IN AUSTRALIA
  • A SYSTEMATIC REVIEW AND META-ANALYSIS OF SURVIVAL CURVE DATA TO DETERMINE THE EFFECTIVENESS OF LIVER AND KIDNEY TRANSPLANTATION IN PERSONS WITH END-STAGE ORGAN FAILURE AND HUMAN IMMUNODEFICIENCY VIRUS
  • MONTE CARLO APPROACH TO CALIBRATION OF DISEASE HISTORY MODELS FOR HEALTH TECHNOLOGY ASSESSMENT: A CASE STUDY
    • Krief, N.
  • ESTIMATING SUBGROUP EFFECTS IN COST-EFFECTIVENESS ANALYSES (CEA): A COMPARISON OF METHODS
    • Kristiansen, I. S.
  • HUMAN PAPILLOMAVIRUS TESTING FOR THE DETECTION OF CERVICAL INTRAEPITHELIAL NEOPLASIA: A SYSTEMATIC REVIEW
  • ESTIMATING SURIVAL GAINS – CAN WE RELY ON “END-OF-STUDY” RESULTS?
  • THE TIME-DEPENDENT COSTS AND BENEFITS OF SCHOOL CLOSURE DURING AN INFLUENZA PANDEMIC
  • TESTING THE ACCURACY OF COMPOSITE HEALTH STATE UTILITY ESTIMATORS – AN ANALYSIS OF MEDICAL CONDITION PAIRS FROM MEPS 2001 AND 2003
  • LEARNING EFFECTS IN EQ-5D TIME TRADE-OFF VALUATIONS
  • COMPOSITE CLINICAL ENDPOINTS: HANDLE WITH CARE?
  • EXPLAINING RISK REDUCTIONS TO PATIENTS: DO PHYSICIANS USE NUMBERS?
  • ORPHAN DRUGS: DOES SOCIETY VALUE RARITY?
  • COST-EFFECTIVENESS OF INTENSIVE LIFESTYLE INTERVENTION IN PATIENTS WITH POORLY CONTROLLED TYPE 2 DIABETES
  • SO MUCH FOR SHARED DECISION MAKING? GENERAL PRACTITIONERS' BELIEFS VERSUS PATIENT PREFERENCES FOR SURVIVAL GAINS
    • Kryworuchko, J.
  • EVALUATING AN H1N1 DECISION AID FOR FAMILIES
    • Kucukyazici, B.
  • CLINICAL DECISION MAKING FOR PREVENTION OF STROKE FROM ATRIAL FIBRILLATION
    • Kulin, N. A.
  • COST-EFFECTIVENESS OF GENE EXPRESSION PROFILING IN EARLY BREAST CANCER
  • PUBLISHED ECONOMIC EVIDENCE TO SUPPORT PERSONALIZED MEDICINE DECISION-MAKING: THE EXAMPLE OF HER2-POSITIVE EARLY BREAST CANCER
  • A PROBABILISTIC DECISION MODEL TO GUIDE OPTIMAL HEALTH POLICY DECISIONS FOR LUNG CANCER SCREENING
    • Kunkel, E.
  • MEDIATED DECISION SUPPORT IN PROSTATE CANCER SCREENING
    • Kuntz, G.
  • WHEN THE DECISION IS WHAT TO DECIDE: LITERATURE OVERVIEWS FOR HTA SCOPING
    • Kuntz, K. M.
  • HOW MUCH NEGATIVE MARGIN IS ENOUGH FOR PATIENTS WITH DUCTAL CARCINOMA IN SITU RECEIVING BREAST CONSERVING SURGERY WITH OR WITHOUT RADIOTHERAPY? A BAYESIAN META-ANALYSIS
  • ASSESSING THE IMPACT OF AN IMPERFECT REFERENCE STANDARD ON ROC ANALYSIS THROUGH SIMULATION
  • COST-EFFECTIVENESS ANALYSIS FOR VARIOUS COLORECTAL CANCER SCREENING STRATEGIES IN TAIWAN
  • PROJECTING LIFE-YEARS GAINED FROM DIRECT-TO-CONSUMER ADVERTISING OF STATIN THERAPY
  • CONCURRENT ORAL SESSION M: SIMULATION AND DECISION MODELING
  • MDM 101: COMMON MDM METHODS AND APPLICATIONS
  • DEVELOPMENT OF A BLOOD TEST TO SCREEN FOR COLORECTAL CANCER: WHICH FEATURES ARE IMPORTANT? A COST-EFFECTIVENESS APPROACH
    • Kuppermann, M.
  • UNDERLYING DIMENSIONS OF SATISFACTION WITH LABOR AND DELIVERY EXPERIENCE: AN EXPLORATORY FACTOR ANALYSIS
    • Kurt, M.
  • THE OPTIMAL TIMING OF PREDIALYSIS PREARRANGED PAIRED KIDNEY EXCHANGES
    • Kutner, J. S.
  • DECISION AIDS NEAR THE END-OF-LIFE, A PILOT RANDOMIZED CONTROLLED TRIAL AND QUALITATIVE EXIT INTERVIEWS
    • Kwong, J.
  • IS A MASS IMMUNIZATION PROGRAM FOR PANDEMIC (H1N1) 2009 GOOD VALUE FOR MONEY? EVIDENCE FROM THE CANADIAN EXPERIENCE
    • Kymes, S. M.
  • EXTERNAL VALIDATION OF A MODEL OF GLAUCOMA PROGRESSION USING INDIVIDUAL LEVEL DATA
  • DEVELOPMENT OF A MULTIATTRIBUTE INSTRUMENT FOR ESTIMATING UTILITIES (PREFERENCE WEIGHTS) IN PEOPLE WITH GLAUCOMA FROM THE NATIONAL EYE INSTITUTE VISION FUNCTION QUESTIONNAIRE
    • Kyriakides, T. C.
  • COST-EFFECTIVENESS OF NOVEL ANTIRETROVIRALS FOR HUMAN IMMUNODEFICIENCY VIRUS INFECTION
    • A B C D E F G H I J K L M N O P Q R S T U V W X Y Z